NEUROD1 rs1801262: What Your Genotype Means
The rs1801262 variant, also known as the Ala45Thr substitution, occurs in the NEUROD1 gene, which encodes a transcription factor critical for pancreatic development. Researchers have investigated this variant for its potential influence on insulin regulation and susceptibility to various forms of diabetes.
What each genotype means
Typical NEUROD1 genotype
This genotype represents the most common form of the NEUROD1 gene found in the general population. It is considered the baseline state, and there is no evidence suggesting this specific configuration contributes to altered beta-cell function or increased diabetes risk.
This is the most common genotype, carried by the vast majority of individuals across all global populations.
Increased diabetes susceptibility marker
You carry one copy of the Ala45Thr variant, which has been associated with potential changes in NEUROD1 transcription factor activity. Research suggests this may influence beta-cell function and could be linked to a higher statistical susceptibility to type 2 or monogenic diabetes, though the evidence remains limited. Please discuss your metabolic health and any family history of diabetes with your healthcare provider.
This genotype is found in approximately 2-6% of individuals of European ancestry, with higher frequencies observed in certain Asian cohorts.
Elevated diabetes susceptibility marker
You carry two copies of the Ala45Thr variant, which may impact the function of the NEUROD1 protein in pancreatic beta-cells. While this variant is associated with an increased statistical risk for diabetes in some studies, the clinical significance is not fully established and evidence is limited. It is recommended to monitor your blood glucose levels and discuss this genetic finding with your physician or a genetic counselor.
This genotype is rare, occurring in less than 1% of most populations, though it may be more frequent in specific ancestral groups.
Understanding the rs1801262 Variant
The rs1801262 variant is a single nucleotide polymorphism (SNP) located within the NEUROD1 gene. In genetic terms, this specific change results in an amino acid substitution where alanine is replaced by threonine at position 45 of the protein sequence, often referred to as Ala45Thr. NEUROD1, or Neurogenic Differentiation 1, is a member of the basic helix-loop-helix (bHLH) family of transcription factors. These proteins act as molecular switches, binding to specific DNA sequences to turn genes on or off. Because this variant is located in a gene essential for the development and function of the endocrine pancreas, scientists have long hypothesized that changes here could alter how the body manages blood glucose levels.
The Role of NEUROD1 in the Pancreas
NEUROD1 plays a vital role in the formation and maintenance of pancreatic beta-cells, the specialized cells responsible for producing and secreting insulin. By forming a complex with other proteins, NEUROD1 binds to the promoter region of the insulin gene, effectively stimulating its expression. When this transcription factor functions correctly, it ensures that beta-cells can respond appropriately to changes in blood sugar. Research has shown that severe mutations in NEUROD1 can lead to Maturity-Onset Diabetes of the Young (MODY), a rare, monogenic form of diabetes. While rs1801262 is a common variant rather than a rare, high-impact mutation, its location within this critical gene has prompted extensive study into whether it subtly impairs the efficiency of insulin production or beta-cell health over time.
Research and Evidence Strength
The evidence linking rs1801262 to diabetes is considered limited and often inconsistent across different populations. Early studies suggested that the variant might influence susceptibility to type 2 diabetes or type 1 diabetes; however, subsequent large-scale meta-analyses have largely failed to confirm a strong, universal association. For instance, while some studies observed a potential increased risk for type 1 diabetes in specific Asian cohorts, these findings have not been consistently replicated in European populations. It is important to note that many genetic variants associated with complex diseases like diabetes have small effect sizes, meaning they contribute only a tiny fraction to an individual's overall risk. Currently, the scientific consensus does not classify rs1801262 as a primary driver of diabetes, and it is not used as a diagnostic tool in clinical settings.
Population Frequency
The frequency of the rs1801262 variant varies significantly depending on ancestral background. In many European populations, the minor allele frequency is relatively low, typically ranging between 1% and 3%. Higher frequencies have been observed in certain Asian cohorts. Because genetic architecture differs across global populations, a variant that appears to have a statistical association in one group may show no such effect in another. This diversity highlights the importance of considering ancestry when interpreting genetic data and underscores why researchers must study large, diverse groups to understand the true impact of any single genetic marker.
Interpreting Your Genetic Information
If you have information about your rs1801262 genotype, it is essential to view it within the context of your overall health. This variant is not a diagnostic test for diabetes, and having a particular genotype does not mean you will develop any specific condition. Diabetes is a complex, multifactorial disease influenced by a combination of genetics, lifestyle, diet, and environmental factors. Genetic testing for common variants like this is generally considered exploratory and should not be used to make medical decisions. If you have concerns about your blood sugar levels, family history of diabetes, or metabolic health, the most effective approach is to consult with a healthcare professional. They can provide personalized guidance based on clinical markers like HbA1c and fasting glucose, which are far more predictive of health outcomes than any single SNP.
How common is this variant?
The minor allele frequency for rs1801262 is approximately 0.01 to 0.03 in European populations, with higher frequencies observed in certain Asian cohorts.
Frequently asked questions
Does the rs1801262 variant cause diabetes?
No, rs1801262 is not considered a direct cause of diabetes. While it is located in a gene involved in insulin regulation, it is a common variant with limited evidence suggesting it significantly increases disease risk.
Should I be worried if I have the T allele?
There is no reason for concern based on this variant alone. Genetic risk for diabetes is complex and determined by many factors; this SNP has a very small, if any, impact on your overall health.
Can I use this information to change my diet?
Genetic information regarding this SNP is not currently used to guide specific dietary changes. You should focus on established healthy lifestyle habits and consult a doctor for personalized nutritional advice.
Is this the same as the gene mutation that causes MODY?
No. MODY6 is caused by rare, high-impact mutations in the NEUROD1 gene that severely disrupt its function. The rs1801262 variant is a common polymorphism and is not associated with the severe, early-onset presentation of MODY.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801262?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29